| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 13 |
| 1 | INFLIXIMAB | 10 |
| 2 | METHOTREXATE SODIUM | 10 |
| 3 | CARBOPLATIN | 9 |
| 4 | METHOTREXATE | 9 |
| 5 | CISPLATIN | 7 |
| 6 | DURVALUMAB | 6 |
| 7 | PACLITAXEL | 6 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 5 |
| 9 | BISOPROLOL FUMARATE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 1 | TREMELIMUMAB | 2 | 0.0005 |
| 2 | DURVALUMAB | 6 | 0.0003 |
| 3 | VINORELBINE | 1 | 0.0001 |
| 4 | PEMBROLIZUMAB | 13 | 0.0001 |
| 5 | GEFITINIB | 1 | 0.0001 |
| 6 | PROCHLORPERAZINE MALEATE | 1 | 0.0001 |
| 7 | FEBUXOSTAT TABLETS 40 MG | 1 | 0.0001 |
| 8 | CISPLATIN | 7 | 0.0001 |
| 9 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 6 | 0.0003 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 15 | 0.0002 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 3 | Platinum-based Drug [EPC] | 15 | 0.0001 |
| 4 | Microtubule Inhibitor [EPC] | 9 | 0.0001 |
| 5 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 9 | 0.0000 |
| 9 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |